Repeated intravenous esketamine treatment in patients with ECT-resistant major depressive disorder

Ketamine is an anesthetic that appears to be an effective and rapidly acting pharmacological treatment in patients with Treatment-Resistant Depression (TRD). However, the definition of TRD varies greatly between published studies, and studies often did not include patients resistant to electroconvul...

Full description

Bibliographic Details

Published in:	Journal of affective disorders reports Vol. 10; p. 100400
Main Authors:	Safai Pour, A., van der Aalst, S.J.M., Brouwer, I.J., Giltay, E.J., Jacobs, G.E., van der Wee, N.J.A., van Hemert, A.M., van Noorden, M.S.
Format:	Journal Article
Language:	English
Published:	Elsevier B.V 01-12-2022 Elsevier
Subjects:	ECT-resistance Esketamine European perspective Major depressive disorder Therapy-resistance Esketamine Therapy-resistance European perspective Major depressive disorder ECT-resistance
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!